SEO URLwww.firestrike.ai/deals/accellix-biom-rieux-acquisition-2026
acquisitionAnnounced · Jan 23, 2026cell and gene therapiesSource · CredibleArticle · Factual
bioMérieux acquires Accellix
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
€35M
Target
Accellix
San Jose, California
Acquirer
bioMérieux
Full Acquisition
Status
Completed
bioMérieux agreed to acquire Accellix. Reported deal value: €35M. Status: Completed. Sector: cell and gene therapies. Target headquarters context: San Jose, California, United States.
This page summarizes publicly available information about the transaction as of 2026-01-23. Figures and status may change as filings and press coverage update.
Since 2020, bioMérieux has been collaborating with Accellix in the cell and gene therapy segment
Deal timeline
Announced
Jan 23, 2026 · investorsinhealthcare.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in cell and gene therapies with a reported deal value of €35M. Figures and status may change as sources update.
Sources: investorsinhealthcare.com · Primary article · FireStrike proprietary index